ConductScience.org, home

Paper7494331

Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.

Heineman TC and 4 others. J Virol, 1995. Cited by 42 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. Papers, record 7494331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7494331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
PubMed
Journal
J Virol
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2020-07-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heineman TCT C
2Connelly BLB L
3Bourne NN
4Stanberry LRL R
5Cohen JJ

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpes GenitalisMajor topic
Herpesvirus 2, HumanMajor topic
Herpesvirus 3, HumanMajor topic
Vaccines, SyntheticMajor topic
Viral Envelope ProteinsMajor topic
Viral VaccinesMajor topic
Animals
Blotting, Southern
DNA, Viral
Female
Guinea Pigs
Humans
Immunization
Microscopy, Immunoelectron

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI15101NIAID NIH HHSUnited StatesR01AI015101PubMed and NIHNIH RePORTER
AI22667NIAID NIH HHSUnited StatesR01AI022667PubMed and NIHNIH RePORTER
AI29687NIAID NIH HHSUnited StatesR01AI029687PubMed and NIHNIH RePORTER

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,833,603A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.J Virol1988https://conductscience.org/library/papers/2833603PubMed
22,826,603Herpes simplex virus glycoprotein treatment of recurrent genital herpes.J Infect Dis1988https://conductscience.org/library/papers/2826603PubMed
31,973,187Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.J Immunol1990https://conductscience.org/library/papers/1973187PubMed
41,849,161Varicella in hairless guinea pigs.J Infect Dis1991https://conductscience.org/library/papers/1849161PubMed
51,646,279Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen.J Gen Virol1991https://conductscience.org/library/papers/1646279PubMed
61,320,650Animal models of varicella.J Infect Dis1992https://conductscience.org/library/papers/1320650PubMed
71,321,283Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration.J Virol1992https://conductscience.org/library/papers/1321283PubMed
81,335,196Current status and prospects of live varicella vaccine.Vaccine1992https://conductscience.org/library/papers/1335196PubMed
98,387,560Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine.J Infect Dis1993https://conductscience.org/library/papers/8387560PubMed
108,394,020Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8394020PubMed
118,151,792Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro.J Virol1994https://conductscience.org/library/papers/8151792PubMed
127,911,177Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.Lancet1994https://conductscience.org/library/papers/7911177PubMed
137,964,618Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin.J Gen Virol1994https://conductscience.org/library/papers/7964618PubMed
147,966,575Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.J Virol1994https://conductscience.org/library/papers/7966575PubMed
157,856,096Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro.Virology1995https://conductscience.org/library/papers/7856096PubMed
1680,458Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.J Virol1978https://conductscience.org/library/papers/80458PubMed
176,286,797Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease.J Infect Dis1982https://conductscience.org/library/papers/6286797PubMed
186,323,270DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene.Gene1983https://conductscience.org/library/papers/6323270PubMed
192,983,428Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.Science1985https://conductscience.org/library/papers/2983428PubMed
203,016,155Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.J Gen Virol1986https://conductscience.org/library/papers/3016155PubMed

See all 27 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
38,003,300The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.Int J Mol Sci2023https://conductscience.org/library/papers/38003300PubMed
36,560,823Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques.Viruses2022https://conductscience.org/library/papers/36560823PubMed
23,843,791Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens.Adv Virol2013https://conductscience.org/library/papers/23843791PubMed
22,133,885HSV-2: in pursuit of a vaccine.J Clin Invest2011https://conductscience.org/library/papers/22133885PubMed
20,225,013The varicella-zoster virus genome.Curr Top Microbiol Immunol2010https://conductscience.org/library/papers/20225013PubMed
18,272,766Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.J Gen Virol2008https://conductscience.org/library/papers/18272766PubMed
17,627,531Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.Curr Pharm Des2007https://conductscience.org/library/papers/17627531PubMed
15,138,167Herpes simplex virus type 2 vaccines: new ground for optimism?Clin Diagn Lab Immunol2004https://conductscience.org/library/papers/15138167PubMed
11,991,985Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.J Virol2002https://conductscience.org/library/papers/11991985PubMed
11,152,015Current recommendations for the treatment of genital herpes.Drugs2000https://conductscience.org/library/papers/11152015PubMed
10,195,045Control of STDs--the role of prophylactic vaccines against herpes simplex virus.Sex Transm Infect1998https://conductscience.org/library/papers/10195045PubMed
8,876,149Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8876149PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACKR12,532PubTator's text mininghttps://conductscience.org/library/genes/2532

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7494331

GET https://conductscience.org/api/papers/v1/7494331/references?page=2